Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 190644 | 87.99 |
09:34 ET | 47444 | 87.3521 |
09:36 ET | 23270 | 87.755 |
09:38 ET | 27343 | 87.615 |
09:39 ET | 12507 | 87.26 |
09:41 ET | 11289 | 87.09 |
09:43 ET | 10774 | 86.95 |
09:45 ET | 14274 | 86.6 |
09:48 ET | 18268 | 87.17 |
09:50 ET | 11790 | 86.97 |
09:52 ET | 16122 | 87.02 |
09:54 ET | 24612 | 87.27 |
09:56 ET | 10670 | 87.36 |
09:57 ET | 19300 | 87.23 |
09:59 ET | 23029 | 87.02 |
10:01 ET | 8502 | 87.2 |
10:03 ET | 13779 | 86.95 |
10:06 ET | 10931 | 86.94 |
10:08 ET | 14884 | 87.11 |
10:10 ET | 6646 | 87.12 |
10:12 ET | 8273 | 86.8601 |
10:14 ET | 3461 | 87.05 |
10:15 ET | 6703 | 86.99 |
10:17 ET | 19746 | 86.735 |
10:19 ET | 7961 | 86.64 |
10:21 ET | 11618 | 86.6442 |
10:24 ET | 22470 | 86.535 |
10:26 ET | 15838 | 86.68 |
10:28 ET | 18733 | 86.61 |
10:30 ET | 2865 | 86.75 |
10:32 ET | 11353 | 86.605 |
10:33 ET | 9895 | 86.41 |
10:35 ET | 16309 | 86.34 |
10:37 ET | 17066 | 86.405 |
10:39 ET | 17358 | 86.605 |
10:42 ET | 5708 | 86.5163 |
10:44 ET | 4439 | 86.625 |
10:46 ET | 12678 | 86.555 |
10:48 ET | 10161 | 86.792 |
10:50 ET | 6856 | 86.85 |
10:51 ET | 7866 | 86.96 |
10:53 ET | 8428 | 87.075 |
10:55 ET | 10425 | 87.095 |
10:57 ET | 12572 | 87.19 |
11:00 ET | 13695 | 87.34 |
11:02 ET | 5774 | 87.385 |
11:04 ET | 16226 | 87.37 |
11:06 ET | 9975 | 87.48 |
11:08 ET | 6276 | 87.46 |
11:09 ET | 16878 | 87.86 |
11:11 ET | 17514 | 88.16 |
11:13 ET | 34439 | 88.48 |
11:15 ET | 14124 | 88.7 |
11:18 ET | 21689 | 88.205 |
11:20 ET | 13792 | 87.995 |
11:22 ET | 27081 | 87.56 |
11:24 ET | 25913 | 87.09 |
11:26 ET | 21687 | 87.1799 |
11:27 ET | 18185 | 87.115 |
11:29 ET | 14785 | 86.96 |
11:31 ET | 10234 | 86.85 |
11:33 ET | 13790 | 86.9 |
11:36 ET | 10252 | 86.93 |
11:38 ET | 4429 | 87.09 |
11:40 ET | 7739 | 87.0991 |
11:42 ET | 7089 | 87.01 |
11:44 ET | 5268 | 87.035 |
11:45 ET | 6756 | 86.9947 |
11:47 ET | 7259 | 87.09 |
11:49 ET | 3279 | 87.13 |
11:51 ET | 5482 | 87.03 |
11:54 ET | 3748 | 87.12 |
11:56 ET | 5468 | 87.0319 |
11:58 ET | 12568 | 86.96 |
12:00 ET | 3244 | 86.98 |
12:02 ET | 3997 | 87.03 |
12:03 ET | 3223 | 86.99 |
12:05 ET | 2988 | 87.05 |
12:07 ET | 3373 | 86.98 |
12:09 ET | 9205 | 86.86 |
12:12 ET | 5457 | 86.86 |
12:14 ET | 5612 | 86.77 |
12:16 ET | 8399 | 86.635 |
12:18 ET | 1905 | 86.71 |
12:20 ET | 4808 | 86.58 |
12:21 ET | 9461 | 86.7201 |
12:23 ET | 2581 | 86.79 |
12:25 ET | 3449 | 86.8505 |
12:27 ET | 2127 | 86.76 |
12:30 ET | 4348 | 86.88 |
12:32 ET | 6339 | 86.9 |
12:34 ET | 2665 | 86.8307 |
12:36 ET | 4246 | 86.95 |
12:38 ET | 6160 | 87.07 |
12:39 ET | 5072 | 87.15 |
12:41 ET | 7107 | 87.02 |
12:43 ET | 5639 | 87.04 |
12:45 ET | 2546 | 87.1 |
12:48 ET | 5840 | 87.2205 |
12:50 ET | 8312 | 87.205 |
12:52 ET | 2142 | 87.16 |
12:54 ET | 8912 | 87.2072 |
12:56 ET | 1854 | 87.27 |
12:57 ET | 6547 | 87.295 |
12:59 ET | 7629 | 87.32 |
01:01 ET | 3453 | 87.31 |
01:03 ET | 3377 | 87.29 |
01:06 ET | 6916 | 87.26 |
01:08 ET | 9365 | 87.25 |
01:10 ET | 1394 | 87.18 |
01:12 ET | 4476 | 87.29 |
01:14 ET | 5801 | 87.29 |
01:15 ET | 11458 | 87.2636 |
01:17 ET | 4233 | 87.27 |
01:19 ET | 25318 | 87.29 |
01:21 ET | 8197 | 87.24 |
01:24 ET | 2791 | 87.235 |
01:26 ET | 2930 | 87.28 |
01:28 ET | 4754 | 87.26 |
01:30 ET | 34975 | 87.28 |
01:32 ET | 8262 | 87.25 |
01:33 ET | 2566 | 87.24 |
01:35 ET | 6549 | 87.13 |
01:37 ET | 3700 | 87.22 |
01:39 ET | 4217 | 87.09 |
01:42 ET | 1600 | 87.07 |
01:44 ET | 6120 | 87.03 |
01:46 ET | 8836 | 87.02 |
01:48 ET | 5430 | 86.85 |
01:50 ET | 4946 | 86.92 |
01:51 ET | 2990 | 86.87 |
01:53 ET | 2000 | 86.89 |
01:55 ET | 1843 | 86.85 |
01:57 ET | 6283 | 86.89 |
02:00 ET | 2170 | 86.85 |
02:02 ET | 2660 | 86.84 |
02:04 ET | 3310 | 86.8 |
02:06 ET | 4148 | 86.78 |
02:08 ET | 6375 | 86.76 |
02:09 ET | 2920 | 86.66 |
02:11 ET | 8243 | 86.35 |
02:13 ET | 5125 | 86.31 |
02:15 ET | 15341 | 86.4 |
02:18 ET | 5739 | 86.51 |
02:20 ET | 3679 | 86.5799 |
02:22 ET | 10161 | 86.39 |
02:24 ET | 5799 | 86.48 |
02:26 ET | 4439 | 86.37 |
02:27 ET | 4141 | 86.56 |
02:29 ET | 5728 | 86.57 |
02:31 ET | 4407 | 86.485 |
02:33 ET | 3354 | 86.45 |
02:36 ET | 4316 | 86.45 |
02:38 ET | 1582 | 86.49 |
02:40 ET | 3300 | 86.52 |
02:42 ET | 5385 | 86.6199 |
02:44 ET | 4301 | 86.53 |
02:45 ET | 6543 | 86.64 |
02:47 ET | 4995 | 86.595 |
02:49 ET | 4157 | 86.565 |
02:51 ET | 6099 | 86.68 |
02:54 ET | 2400 | 86.6 |
02:56 ET | 11329 | 86.62 |
02:58 ET | 6916 | 86.58 |
03:00 ET | 9193 | 86.52 |
03:02 ET | 6072 | 86.605 |
03:03 ET | 9074 | 86.84 |
03:05 ET | 7261 | 86.97 |
03:07 ET | 3361 | 86.895 |
03:09 ET | 3353 | 86.78 |
03:12 ET | 1800 | 86.8 |
03:14 ET | 2889 | 86.8 |
03:16 ET | 1664 | 86.91 |
03:18 ET | 2227 | 86.79 |
03:20 ET | 2705 | 86.82 |
03:21 ET | 3426 | 86.83 |
03:23 ET | 5802 | 86.81 |
03:25 ET | 4016 | 86.92 |
03:27 ET | 4032 | 86.7905 |
03:30 ET | 2572 | 86.83 |
03:32 ET | 3910 | 86.785 |
03:34 ET | 3142 | 86.885 |
03:36 ET | 3023 | 86.9 |
03:38 ET | 5521 | 86.84 |
03:39 ET | 3914 | 86.87 |
03:41 ET | 4220 | 87.07 |
03:43 ET | 8098 | 87.1 |
03:45 ET | 15413 | 87.02 |
03:48 ET | 8774 | 86.975 |
03:50 ET | 7900 | 86.915 |
03:52 ET | 9455 | 86.9099 |
03:54 ET | 16992 | 86.74 |
03:56 ET | 21647 | 86.785 |
03:57 ET | 28210 | 86.955 |
03:59 ET | 368035 | 86.84 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 33.4B | -5.7x | --- |
ICON PLC | 26.7B | 39.1x | +4.68% |
Biogen Inc | 29.4B | 25.4x | -18.14% |
Biontech SE | 20.3B | -36.9x | --- |
Grifols SA | 5.8B | 28.9x | --- |
Alnylam Pharmaceuticals Inc | 34.4B | -426.8x | --- |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $33.4B |
---|---|
Revenue (TTM) | $5.1B |
Shares Outstanding | 384.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.71 |
EPS | $-15.37 |
Book Value | $36.27 |
P/E Ratio | -5.7x |
Price/Sales (TTM) | 6.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -91.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.